Key Players Of Covid-19 Vaccine
25 Nov, 2020
Vaccine makers are racing against time to develop a vaccine to fight the novel coronavirus.
AZD1222, formerly known as ChAdOx1 nCoV-19, is being developed by the University of Oxford and AstraZeneca plc (AZN).
mRNA-1273 is being developed by U.S.-based Moderna Inc. (MRNA) and the National Institute of Allergy and Infectious Diseases (NIAID).
BNT162 is being developed by Germany-based BioNTech SE (BNTX) and Pfizer Inc. (PFE).
INO-4800 is being developed by US-based Inovio Pharmaceuticals Inc. (INO) and is under phase trial I in U.S.
NVX-CoV2373 is being developed by US-based Novavax Inc. (NVAX) and under a phase I/II trial.
Ad5-nCoV is being developed by China's CanSino Biologics Inc and is under a phase II trial in China.
CoronaVac is being developed by China-based Sinovac Biotech Ltd. (SVA) and is under a phase I/II trial in China.
BBIBP-CorV is being developed by the Beijing Institute of Biological Products affiliated to state-owned China National Pharmaceutical Group, known as known as Sinopharm.
A vaccine is being developed by Wuhan Institute of Biological Products, affiliated to state-owned China National Pharmaceutical Group - Sinopharm.
A vaccine is being developed by the Institute of Medical Biology and the Chinese Academy of Medical Sciences.